Staging System to Predict the Risk of Relapse in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation

Over the last decade autologous stem cell transplantation (ASCT) has emerged as the standard of care in the management of Multiple Myeloma (MM). However, the cases of early relapse (within 36 months) after the stem cell rescue remains a significant challenge. For a lot of practical purposes, it is c...

Descripción completa

Detalles Bibliográficos
Autores principales: Goswami, Chitrita, Poonia, Sarita, Kumar, Lalit, Sengupta, Debarka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6640159/
https://www.ncbi.nlm.nih.gov/pubmed/31355145
http://dx.doi.org/10.3389/fonc.2019.00633

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6640159/
https://www.ncbi.nlm.nih.gov/pubmed/31355145
http://dx.doi.org/10.3389/fonc.2019.00633

Ejemplares similares